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a b s t r a c t
Cartilage tissue engineering (TE) typically involves the combination of a 3-D biodegradable polymeric
support material, with primary chondrocytes or other cell types able to differentiate into chondrocytes.
The culture environment in which cell–material constructs are created and stored is an important factor.
Various bioreactors have been introduced in TE approaches to provide speciﬁc culturing environments
that might promote and accelerate cells’ potential for chondrogenic differentiation and enhance the pro-
duction of cartilage extracellular matrix. The aim of the present study was to investigate the chondro-
genic differentiation of goat bone marrow cells (GBMCs) under ﬂow perfusion culture conditions. For
that purpose, GBMCs were seeded into starch–polycaprolactone ﬁber mesh scaffolds and cultured in a
ﬂow perfusion bioreactor for up to 28 days using culture medium supplemented with transforming
growth factor-b1. The tissue-engineered constructs were characterized after several end points (7, 14,
21 and 28 days) by histological staining and immunocytochemistry analysis, as well as by glycosamino-
glycan and alkaline phosphatase quantiﬁcation assays. In addition, the expression of typical chondrogenic
markers was assessed by real-time reverse-transcription polymerase chain reaction analysis. In general,
the results obtained suggest that a ﬂow perfusion microenvironment favors the chondrogenic potential of
GBMCs.
 2010 Published by Elsevier Ltd. on behalf of Acta Materialia Inc.
1. Introduction
Hyaline cartilage is an avascular, aneural and alymphatic, but
highly specialized, type of connective tissue [1–3]. Cartilage is
composed by chondrocytes that produce a large amount of extra-
cellular matrix (ECM), made of collagen ﬁbrils, predominantly type
II collagen and link proteins such as proteoglycans (PGs), aggrecan
and hyaluronic acid [4–6]. Cartilage, found within many joints, is
responsible for the correct functionality of the articulating skele-
ton, creating smooth gliding areas in the terminal parts of long
bones for shock absorbance, load bearing and reduction of surface
friction [1,2].
Damaged articular cartilage shows a limited capacity for self-
regeneration [1,5] due to the low metabolic activity and prolifera-
tion rates of mature chondrocytes, and because of the absence of
either vascular or lymphatic vessels [2,4,6]. These limitations led
to the development of surgical methods for restoring cartilage sur-
face; however, to date, none of these procedures has been able to
reliably reproduce hyaline cartilage.
Cartilage tissue engineering (TE) appears to be a promising ap-
proach for improving the quality and longevity of repaired tissue
[7]. The general principle of cartilage TE involves a natural/syn-
thetic biodegradable material or scaffold combined with chondro-
cytes or mesenchymal stromal cells to build a three dimensional
(3-D) living construct functionally, structurally and mechanically
similar to the tissue to be replaced [5]. Several combinations of
materials processed into 3-D porous scaffolds or hydrogels, and
various cell types have been used in cartilage TE strategies [8].
Mesenchymal stromal cells (MSCs), due to their ability to prolifer-
ate extensively ex vivo, while maintaining multipotent differentia-
tion properties, are an attractive cellular source for cell-based
cartilage repair strategies [6,9–12]. In vitro chondrogenic differen-
tiation of MSCs involves complex interfaces of growth factors, cell–
cell and cell–matrix interactions. Many studies have demonstrated
the chondrogenic differentiation of MSCs in the presence of the
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transforming growth factor-b family [8,11], whose members are
known to induce the expression of cartilage-speciﬁc genes and
ECM deposition [2].
Bioreactor studies have focused on the inﬂuence of mechanical
stimuli on the proliferation and differentiation of MSCs [11,13].
Therefore, the design of bioreactors constitutes another important
element for TE strategies, as these culturing systems provide opti-
mized environments for in vitro functional 3-D tissue development
[14–16]. Problems associated with poor diffusion under tradition-
ally static culturing conditions can be mitigated using a ﬂow perfu-
sion bioreactor, in which media is forced into the scaffold pores
[9,14,17]. A ﬂuid ﬂow culture system not only provides more efﬁ-
cient nutrient supply and metabolite removal, but also furnishes a
physiochemical environment favorable for stimulating undifferen-
tiated cells into target phenotypes [13,17].
The present work investigates the inﬂuence of cell culture con-
ditions generated by a ﬂow perfusion bioreactor system on the
proliferation and chondrogenic differentiation of goat bone mar-
row stromal cells (GBMCs) seeded onto starch–polycaprolactone
(SPCL) scaffolds.
2. Materials and methods
2.1. Preparation of biodegradable supports—SPCL ﬁber mesh scaffold
Fiber-mesh scaffolds based on SPCL (a blend of corn starch and
polycaprolactone, 30/70 wt.%) were prepared by ﬁber bonding, a
technique that consists of cutting and sintering ﬁbers previously
obtained by melt-spinning [18]. Scaffolds were cut into samples
8 mm in diameter and 3.5–4 mm high, and then sterilized with
ethylene oxide.
2.2. Goat bone marrow stromal cell culture and chondrogenic
differentiation
GBMCs were harvested from the iliac crest of adult goats and
expanded until passage 3 (P3) in low-glucose Dulbecco’s modiﬁed
essential medium (DMEM; Sigma Chemical Co., St. Louis, MO, USA)
supplemented with 1% antibiotic/antimycotic (Sigma) and 10% fe-
tal bovine serum (FBS; Sigma) [1]. The cells used in this study were
harvested from the same animal, as GBMCs had previously been
expanded and cryopreserved under the same conditions. The only
difference is that different vials of the same lot of cells were
thawed and used in the pellet and SPCL scaffold studies.
2.2.1. Pellet culture system
The potential of GBMCs to undergo chondrogenic differentia-
tion was assessed by culturing cell pellets. For the preparation of
each pellet, aliquots of 2.5  105 cells in 0.5 ml of medium were
centrifuged at 1500 rpm for 15 min in a 15 ml polypropylene con-
ical tube. Pellets were then cultured for 28 days in a 37 C humid-
iﬁed atmosphere including 5% CO2; the medium was changed once
a week. The medium used for chondrogenic differentiation was
composed by low-glucose DMEM (Sigma), 1% antibiotic/antimicot-
ic (Sigma), and 5% FBS supplemented with 10% Insulin–Transfer-
rin–Selenium (ITS(+); Sigma), 17 mM L-ascorbic acid (Sigma),
0.1 M sodium pyruvate (Sigma), 35 mM L-proline (Sigma), 1 mM
dexamethasone (Sigma) and 10 ng ml1 TGF-b1 (Sigma–Aldrich,
Portugal).
2.2.2. Cell seeding onto SPCL scaffolds
After reaching conﬂuence, GBMCs were detached using trypsin/
EDTA (0.05% w/v trypsin/0.02% EDTA; Sigma). Cells (P3) were then
centrifuged at 1200 rpm for 5 min and resuspended in basal med-
ium. Subsequently, SPCL scaffolds were placed in non-adherent 48-
well plates and seeded with a 150 ll cell suspension containing
5  105 cells, followed by 2 h incubation. Afterwards, 500 ll of ba-
sal medium was added to each well, and incubated overnight to
enable cell attachment. On the following day, samples were trans-
ferred to other well-plates and kept either in static conditions or
moved into the bioreactor system.
2.2.3. Cell culture: ﬂow perfusion bioreactor
The ﬂow perfusion bioreactor used in this study was developed
by the 3B’s Research Group [19,20]. The system is composed of 20
culture chambers, each one supporting a single, tightly ﬁtting scaf-
fold. A peristaltic pump controls the medium ﬂow rate through the
bioreactor, with silicon tubes directly connected to the system and
to a medium reservoir. In this experiment, a continuous ﬂow rate
of 0.1 ml min1 was induced for each scaffold, keeping the total
volume in the ﬂow system at 100 ml. The chondrogenic medium
was then added to constructs from both culturing conditions (sta-
tic and ﬂow perfusion), and medium changed once a week. 0.5 ml
medium was also added to each cell–SPCL construct kept under
static culture. Control constructs were cultured in DMEM. All
GBMC–SPCL constructs were maintained in a 37 C environment
with 5% CO2. SPCL scaffolds without cells were also kept under
the same conditions and used as negative controls.
2.3. Characterization of pellets and cell–scaffold constructs
2.3.1. Cell metabolic activity
Cellular metabolic activity was assessed by MTS assay. Culture
mediumwas removed and samples were rinsed in PBS. Afterwards,
MTS reagent (VWR, Portugal) was added, and incubated for 3 h.
MTS precipitate, produced by metabolically active cells in culture,
was quantiﬁed by spectrophotometry at A490 nm, using a micro-
plate reader (Bio-Tek, Synergie HT, USA).
2.3.2. Cell proliferation
To estimate the cellular proliferation rate during the culture
time, double-stranded DNA (dsDNA) content was measured using
a ﬂuorimetric PicoGreen dsDNA Quantiﬁcation Kit (P7589, Invitro-
gen, Molecular Probes, USA). For this purpose, samples collected
after each end point were carefully rinsed in PBS, and kept in
1 ml ultrapure water at 80 C until usage. Prior to DNA quantiﬁ-
cation, samples were thawed and sonicated for 15 min. Experimen-
tal samples and standards (0–2 lg ml1) were added to a white
opaque 96-well plate. The followed procedure was based on the
manufacturer instructions. Fluorescence was quantiﬁed using a
microplate reader described above at an excitation of A485/20 and
at an emission of A528/20.
2.3.3. Alkaline phosphatase quantiﬁcation
Alkaline phosphatase (ALP) activity was measured using a col-
orimetric endpoint assay which quantiﬁed the conversion of p-
nitrophenol phosphate to p-nitrophenol by ALP enzyme. Brieﬂy,
samples and a substrate solution of 0.2% (w/v) p-nitrophenyl phos-
phate (Sigma) in a substrate buffer of 1 M diethanolamine HCl
(Merck, Germany) were added to a 96-well plate. After 1 h of incu-
bation, a stop solution (2 M NaOH (Panreac) plus 0.2 mM EDTA
(Sigma)), was added to each well, and the absorbance read at
405 nm in a microplate reader. A standard curve was made from
standards (0–0.3 lmol ml1) prepared with a p-nitrophenol
(pNP; Sigma) solution. Sample and standard triplicates were ana-
lyzed and sample concentrations read off from the standard curve.
2.3.4. Glycosaminoglycan content
The presence of PGs was determined by measuring the level of
sulfate glycosaminoglycans (GAGs) using a 1,9-dimethylmethylene
blue (DMB; Aldrich) dye-binding assay and quantiﬁed using a
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6-sulfate chondroitin standard curve. Samples were digested in a
sodium phosphate-buffered protein k (Sigma) solution at 60 C
overnight. After the digestion was completed, samples and chon-
droitin sulfate standards were placed in a 96-well plate followed
by a DMB metachromatic solution. The optical density was mea-
sured using a microplate reader at A520/530 nm. A standard curve
was created and GAG values of the samples were read off from
the standard graph.
2.3.5. Scanning electron microscopy
GBMC–SPCL interactions, cellular adhesion and proliferation
were observed by scanning electron microscopy (SEM). Represen-
tative samples of each culture condition at each end point (7, 14,
21 and 28 days) were rinsed in PBS and ﬁxed in a solution of
2.5% glutaraldehyde (in PBS). Before sputter coating with gold,
samples were dehydrated in a gradient series of ethanol solutions
and air dried at room temperature. Samples were then observed
using a scanning electron microscope (Leica Cambridge S360, Leica
Cambridge, UK).
2.3.6. Histological and immunocytochemistry analysis
2.3.6.1. Pellet characterization. Pellets were rinsed in PBS, ﬁxed in
4% formalin, embedded in parafﬁn and cut into 2.5 lm sections.
In order to observe cells and matrix formed, sections were identi-
ﬁed with hematoxylin & eosin (H&E; Sigma). PGs and GAGs were
stained with Alcian blue (1%, Sigma), Toluidine blue (1%, Sigma)
and Safranin O (0.1%, Fluka), which are frequently used as
cartilage-speciﬁc stainings. Type IIA collagen was detected by
immunocytochemistry using a RTU Vectastain Universal Elite
ABC Kit Pk-7200 and a Vector DAB Kit (Vector Laboratories Ltd.,
UK). The procedure was based on the protocol provided by the
manufacturer. Samples were then visualized under a light micro-
scope (Stemi 1000 PG-HITEC Zeiss) and images taken with an at-
tached camera (Axion MRc5, Zeiss).
2.3.6.2. GBMC–SPCL construct characterization. GBMC–SPCL con-
structs were rinsed in PBS and ﬁxed with 4% formalin. Constructs
were directly stained with Safranin O, and then visualized with a
stereomicroscope (Stemi 2000 Zeiss) equipped with an imaging
camera (PowerShot G6, Canon).
2.3.7. Measurement of mRNA level by real-time reverse-transcription
polymerase chain reaction
mRNA expression of the genes of interest was measured in the
pellet culture systems as well as in the GBMC–SPCL constructs,
both in static and dynamic culture conditions, by real-time re-
verse-transcription polymerase chain reaction (RT-PCR) analysis.
Total RNA was extracted using TRIzol (Invitrogen, USA) following
the manufacturer’s instructions. First-strand complementary DNA
(cDNA) was synthesized from 1 lg RNA using the iScript cDNA
synthesis Kit (BioRad, USA) in a 20 ll reaction. The amount of
cDNA was measured by quantitative PCR method using iQ SYBER
Green SuperMix (VWR, Portugal), according to the manufacturer’s
instructions, in a 25 ll reaction containing 5 ll of primers. The pri-
mer sequence, with speciﬁcity for goat, was obtained from Primer3
software (v 0.4.0) for GAPDH, type II and type I collagen and Sox 9
genes, and synthesized by MWG Biotech Germany (see Table 1).
Relative quantiﬁcation was calculated using the 2DCt method for
pellets and 2DDCt method for GBMC–SPCL constructs [21]. mRNA
expression levels of target genes were normalized to an endoge-
nous housekeeping gene, GAPDH. Undifferentiated GBMCs seeded
onto SPCL scaffolds cultured in basic medium with DMEM (7, 14,
21 and 28 days) were used as calibrators.
2.4. Statistical analysis
All values are presented as mean ± standard deviations. For sta-
tistical analysis multiple-pairs comparison have been performed
using one-way ANOVA followed by the Tukey–Kramer method
with a signiﬁcance level of 95% (P < 0.05).
3. Results
3.1. Pellet system culture
In our experiment, the chondrogenic potential of the isolated
GBMC population was studied and conﬁrmed in vitro using pellet
culture systems for up to 28 days. This is a 3-D cell culture tech-
nique designed to improve the differentiation of stromal cells into
chondrocytes in the presence of a chondrogenic differentiation fac-
tor, TGF-b1. Cell proliferation was evaluated at different end points
(7, 14 and 28 days) (Fig. 1), showing a tendency to decrease with
the time in culture.
The cellular metabolic activity showed a decrease from day 7 to
day 14, followed by an increase in cell viability from day 14 to day
28 (P < 0.05), indicating that low DNA values are not related to cell
death, but are probably involved in the chondrogenic differentia-
tion process (Fig. 2).
Examination of histological sections of pellets harvested after 7
and 28 days in culture and stained with H&E showed no notable
morphological differences with time (Fig. 3A, B). An intense color
developed by Alcian blue, Toluidine blue and Safranin O stainings
indicated the presence of PGs and GAGs in the pellet structures
(Fig. 3C–H), suggesting that cartilaginous matrix had been
synthesized.
Table 1
Goat chondrogenic primer pairs.
Gene Amplicon (bp) Primers ID number
GAPDH 176 F-50 GGGTCATCATCTCTGCACCT 30
R-50 GGTCATAAGTCCCTCCACGA 30
AJ431207
Col IIA 101 F-50 CTGGATGCCATGAAGGTTTT 30
R- 50 CTCTTGCTGCTCCACCAGTT 30
FJ178374
Sox 9 243 F-50 TGAAGAAGGAGAGCGAGGAG 30
R-50 TGCCCAGAGTCTTGCTGAG 30
EF203710
Col I 167 F-50 GGTGACAGGAAGTCCCAGAA 30
R-50 CCATCGTAGGTGACGCTGTA 30
FJ200436
Fig. 1. DNA quantiﬁcation of pellets harvested at different time periods of culture.
Results presented represent mean ± SD. ⁄Statistically signiﬁcant differences
(P < 0.05).
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These ﬁndings were further supported by immunocytochemical
results, which detected type IIA collagen, a major protein of carti-
laginous ECM (Fig. 4) in pellets from every culture time studied.
Total mRNA was extracted from GBMCs pellets at different cul-
ture times. The mRNA of different genes was measured and nor-
malized to the expression of housekeeping GAPDH. The mRNA
expression of Sox9, type IIA and type IA collagen was detected in
all pellets and some signiﬁcant differences were found in some
time points (Fig. 5). Despite the higher expression of Sox9 through
time, type IIA collagen had expression values superior to type IA
collagen (also strongly detected by immunocytochemical analysis).
3.2. GBMC–SPCL constructs in ﬂow perfusion culture
Constructs harvested from the bioreactor and static cultures
were characterized with respect to dsDNA content and cellular
metabolism after 0, 7, 14, 21 and 28 days. Comparing the static cul-
ture with the ﬂow perfusion system, differences in levels are evi-
dent both for cellular metabolism and proliferation rates (Fig. 6A
and B). The GAG content (Fig. 6C) in the constructs seems to be
higher when cells were cultured under static conditions. However,
the GAG content increased up to 7 days, followed by maintenance
levels under static and dynamic cultures. Constructs from both cul-
ture conditions exhibited low ALP activity values (Fig. 6D), and the
lowest values were registered for constructs kept under continu-
ous ﬂow perfusion.
Fig. 2. Cell viability assay of GBMCs pellets using MTS reagent. Results presented represent mean ± SD. ⁄Statistically signiﬁcant differences (P < 0.05).
Fig. 3. Light microscopy images obtained from pellets sections after H&E staining (A and B); Alcian blue staining (C and D); Toluidine blue (E and F) and Safranin O (G and H).
Scale bar = 100 lm.
Fig. 4. Images obtained from pellets sections that were immunocytochemically
stained for collagen type IIA after 7 and 28 days of culture in the presence of TGF-b
(positively stained and control section). Scale bar = 100 lm.
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SEM analysis showed that cells seeded onto the SPCL scaffolds
were round in shape, a morphology typical of chondrocytes
(Fig. 7A and B). This morphology was observed in both static and
ﬂow perfusion conditions. However, after 28 days in chondrogenic
culture, cells started to modify their shape (data not shown).
To conﬁrm the presence of PGs in the ECM, Safranin O staining
was performed directly on the GBMC–SPCL constructs. All scaffolds
used for Safranin O analysis are cell-seeded scaffolds, and Safranin
O staining was homogeneously detected on the scaffold surface.
The formation of ECM was detected in higher-magniﬁcation pic-
tures by a darker red staining in some areas of the cultured scaf-
folds (Fig. 8).
After 4 weeks in chondrogenic medium culture supplemented
with TGF-b1, real-time RT-PCR was performed to evaluate the
mRNA expression of Sox9, collagen IIA and collagen IA genes in
the GBMC–SPCL constructs cultured under ﬂow and static condi-
tions. Sox9 is an important regulator of the chondrocytic pheno-
type and controls the expression of collagen IIA. The results are
reported in Fig. 9. In general, cells cultured under different condi-
tions showed different levels of gene expression. In particular,
the ﬂow perfusion culture seemed to enhance gene expression,
and this is quite evident when comparing the expression of Sox9,
Fig. 5. mRNA expression of Sox9, Col II and Col I of pellets at different culture times,
relative to the housekeeping GAPDH. Symbols indicate statistically signiﬁcantly
different (P < 0.05) expression levels at different time points.
Fig. 6. GBMC–SPCL constructs cultured under chondrogenic medium in static and ﬂow perfusion condition for 28 days: (A) cellular metabolic activity with MTS assay; (B)
DNA content; (C) DMB assay for GAG quantiﬁcation; (D) ALP activity.
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collagen IIA and collagen I to the values obtained for static culture.
Higher expression of Sox9 is detected in an earlier stage of differ-
entiation after 7 days in culture, while collagen IIA is highly
expressed in the last culture end point (28 days).
4. Discussion
Mesenchymal progenitor cells with chondrogenic potential are
present in many tissues of the body [10,12]. Those from bone mar-
row are of particular interest because of the ease of harvesting and
their potential for autologous therapies promoting cartilage repair.
Numerous studies have demonstrated that cells isolated from bone
marrow can undergo in vitro osteogenic and/or chondrogenic dif-
ferentiation under suitable culturing conditions [1,3,14]. The chon-
drogenic differentiation of MSCs from adult bone marrow involves
a rapid biosynthesis of PGs and GAGs, the deposition of an inte-
grated ECM, and is also accompanied by a dramatic alteration of
cells into a round shaped morphology. This process is inﬂuenced
by a number of key factors, including 3-D culture format, low oxy-
gen tension and the presence of appropriate growth factors [22].
In this study, we ﬁrst evaluated the ability of GBMCs to differen-
tiate into the chondrogenic lineage through the pellet experiment.
After the characterization of the chondrogenic differentiation pro-
cess in GBMCs, we proceeded to the major goal of our study: the
evaluation of the effect of ﬂow perfusion in the chondrogenic differ-
entiation of GBMCs seeded onto SPCL scaffolds.
4.1. Pellet system culture
This work describes the chondrogenic differentiation potential
of mesenchymal progenitor cells from goat marrow, using SPCL
scaffolds, to assemble cartilage-like tissue-engineered constructs
Fig. 7. SEM micrographs of the SPCL seeded with GBMCs and cultured in chondrogenic medium: (A) static condition; (B) ﬂow perfusion condition.
Fig. 8. Safranin O staining in SPCL–GBMC constructs. Scale bar = 1 mm.
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under different culture conditions. GBMCs have been used in bone
[23,24], cartilage [25,26] and also osteochondral [6,27] TE.
In this study, TGF-b1 and dexamethasonewere used as factors to
induce chondrogenic differentiation. TGF-b1 provides a cellular
stimulus for differentiation, regardless of the number of cells with
chondrogenic capacity. In the pellet culture system, the addition
of TGF-b1 provided the appropriate external signal which, when
coupled with endogenous factors, communicated between cells
within the condensation, and facilitated chondrogenic differentia-
tion [22,28]. The results on cell proliferation and metabolic activity
rates (Figs. 1 and 2) showed that GBMCs delay the proliferation rate
until day 28, while they differentiate into the chondrogenic lineage,
i.e. pellets display an initial phase of cell proliferation, followed by
matrix deposition (Figs. 3 and 4). The positive staining areas for
chondrocytic markers increased with culture time. After 28 days
in culture almost all pellets are strongly stained for the different
cartilage-speciﬁc stainings (Fig. 3A–H). Immunoreactivity for type
IIA collagen also indicates that GBMCs undergo chondrogenic dif-
ferentiation. Positive immunocytochemical staining was observed
at all end points, but stronger staining areas were found after
28 days in chondrogenic medium, mainly located at the border
layer of GBMC pellets (Fig. 4) [22]. Results from real-time RT-PCR
conﬁrmed the expression of three important and typical chondro-
genic markers. Sox9 gene expression was up-regulated earlier in
the ﬂow culture compared to the static culture, which indicated
an initial onset of chondrogenesis [29]. Gene expression of Sox9 ob-
served on day 7 also suggested that GBMCs release signaling factors
involved in the regulation of the chondrogenic differentiation.
In summary, the presence of Safranin O-, Toluidine blue- and
Alcian blue-stained matrix, the chondrogenic morphology of cells,
and the detection of type II collagen protein as well as Sox9 gene,
clearly demonstrated the ability of goat marrow-derived cells to
generate a ‘‘cartilage-like’’ tissue [22,30].
4.2. GBMC–SPCL constructs in ﬂow perfusion culture
We next analyzed the chondrogenic potential of GBMCs com-
bined with SPCL scaffolds cultured under ﬂow perfusion or static
conditions. In previous studies, SPCL ﬁber-mesh scaffolds have
been shown [1] to support the proliferation and differentiation of
bovine articular chondrocytes, demonstrating the potential of our
study as a valid alternative strategy for cartilage TE.
Chondrocytes have been described as cells with low prolifera-
tive and migration rates but a high potential to form cellular aggre-
gates. Considering that GBMCs have the potential to differentiate
into the chondrogenic lineage with low movement potential,
determined by the pellet experiment, this study was mainly fo-
cused on the effect of mechanical stimulation, promoted by the
ﬂow perfusion, to stimulate the chondrogenic differentiation of
GBMCs.
Bioreactors are culture devices in which medium circulates
dynamically, enhancing nutrient and metabolite transport, as well
as mechanical stimulation, thus promoting tissue growth [31]. This
system has been used to improve proliferation and differentiation
of cells. Different bioreactors are used for different strategies and
ﬂow perfusion bioreactors are well known for inducing osteogenic
differentiation [14]. An overview of the proliferation rate showed
that during the ﬁrst 7 days, DNA values are quite similar under
both static and dynamic conditions, followed by a signiﬁcant de-
crease in proliferation at week 2 in ﬂow perfusion culture, while
in static conditions DNA values are maintained through the exper-
imental time (Fig. 6A and B). This can be associated with an earlier
differentiation of GBMC–SPCL constructs under ﬂow perfusion con-
ditions. When cells differentiate, the proliferation rate decreases
because a higher amount of cellular energy is taken by the synthe-
sis of ECM matrix proteins rather than for cell replication and pro-
liferation. However, the mechanism behind the direct perfusion on
chondrogenic differentiation is not well understood and differ-
ences between reports may be related to the type of scaffolds or
bioreactor systems used [32]. The main point, when comparing
Fig. 9. Graphical representation of the results obtained from real-time RT-PCR
analysis regarding the expression of different chondrogenic marker genes according
to the culture condition.
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the results obtained in static and ﬂow perfusion culture of GBMC–
SPCL constructs, is to analyze the evolution of the chondrogenic
markers involved in this process.
SEM micrographs revealed that GBMCs seeded onto SPCL ﬁbers
had a round shaped morphology, typical of chondrocytic cells, un-
der both static and ﬂow perfusion conditions.
Concerning ECM production, GBMC–SPCL constructs stained
Safranin O throughout the scaffold; in higher-magniﬁcation pic-
tures, darker areas correlate to a higher amount of ECM.
After 4 weeks in culture, the analysis of gene expression indi-
cated that different stages of chondrogenic differentiation are dis-
tinguished in both cultures. However, it is important to highlight
that, in general, the ﬂow perfusion culture showed higher values
of gene expression for all analyzed genes (Fig. 9). In an initial stage,
Sox9 mRNA is overexpressed at day 7 in both cultures (Fig. 9,
Sox9). Sox9 is a master transcriptional factor (TF) required for
chondrocyte differentiation [33]. This nuclear TF is an early marker
expressed in cells undergoing differentiation, and is required for
the gene expression of type IIA collagen (Col2a1) and other carti-
lage-speciﬁc matrix proteins [34]. Collagen II is a well-known mar-
ker of cartilage ECM, usually expressed at the ﬁnal stage of the
chondrogenic differentiation process. Furthermore, Sox9 might
also control the expression of genes encoding cell surface proteins
desirable for mesenchymal condensation [33]. Our results showed
a higher value of type IIA collagen gene expression at day 7 when
compared to day 14 in static culture (Fig 9, Collagen IIA). Unlike
type IIA collagen, type I (Col1a1) collagen expression increased be-
tween 7 and 14 days of culture. At this stage, cells could be consid-
ered as pre-chondrogenic cells [34]. Prior to condensation, pre-
chondrocyte cells produce hyaluronic and type I collagen-rich
ECM, as well as type IIA collagen. The amount of type II pro-colla-
gen is controlled at the molecular level by the transcription of
mRNA from Col2a1 gene. In addition, type II collagen can be ex-
pressed in two isoforms by differential splicing of the primary gene
transcript, using a post-transcription control mechanism. Since
type II collagen alpha 1 expression is up-regulated, a different
splice variant of the gene, the type IIB, might be expressed instead
of type IIA [34,35]. The variant of type II collagen being expressed
was not identiﬁed, but could explain the decrease in Col IIA mRNA
values detected in both cultures.
In the ﬁnal culture end point, day 28, GBMCs might have
emerged into a chondrocyte-like stage, supported by the fact that,
at this level, mRNA expression of Sox9 is turning off and mRNA lev-
els of type IIA collagen increased, when compared to other cultur-
ing times [35].
ALP was included in this study as a hypertrophy marker to de-
tect if GBMCs were differentiating into hypertrophic chondrocytes
at a later stage of the differentiation process. Hypertrophic chon-
drocytes are characterized by a simultaneous increase in ALP and
type I collagen levels. Although at the 2 week end point, an in-
crease in the expression of these two markers is observed, related
to cellular condensation, hypertrophy is described to occur only
after 4 weeks in chondrogenic culture [35].
5. Conclusions
In this study SPCL scaffolds seeded with GBMCs in a chondro-
genic medium supplemented with TGF-b1 showed enhanced
mRNA expression for chondrogenic genes and enhanced produc-
tion of ECM when cultured under dynamic (ﬂow perfusion) condi-
tions. The production of ECM is crucial for the chondrogenic
differentiation process, because ECM is the main tissue support.
In this sense, larger amounts of ECM produced in vitro are likely
to promote better results after in vivo implantation. In conclusion,
the ﬂow perfusion system used in this work seemed to create a
favorable environment to promote the chondrogenic differentia-
tion of GBMCs cultured onto SPCL ﬁber meshes, and therefore with
the potential to produce in vitro highly functional constructs for
further in vivo implantation.
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Appendix A. Figures with essential colour discrimination
Certain ﬁgures in this article, particularly Figures 3, 4 and 8, are
difﬁcult to interpret in black and white. The full colour images can
be found in the on-line version, at doi:10.1016/j.actbio.2010.
11.044.
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